Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HERBALIFE LTD. Director's Dealing 2023

Jul 10, 2023

32337_dirs_2023-07-10_8f7d263c-ae29-420c-a127-889d47973328.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: HERBALIFE LTD. (HLF)
CIK: 0001180262
Period of Report: 2023-07-01

Reporting Person: Montesino Ibelis (EVP & Chief of Staff)

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 144619 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Appreciation Rights $13.60 2033-05-04 Common Stock (80049) Direct

Footnotes

F1: Balance includes 144,619 unvested restricted stock units ("RSUs") previously granted to the Reporting Person, of which: 10,096 were granted on August 8, 2020, of which 100% will vest on August 8, 2023; 8,276 were granted on February 19, 2021, of which 20% vested on February 19, 2022, 20% vested on February 19, 2023, and 60% will vest on February 19, 2024; 10,920 were granted on February 25, 2022, of which 20% vested on February 25, 2023, 20% will vest on February 25, 2024, and 60% will vest on February 25, 2025; 14,236 were granted on November 2, 2022, of which 20% will vest on November 2, 2023, 20% will vest on November 2, 2024, and 60% will vest on November 2, 2025; 94,637 were granted on December 9, 2022 and will vest 100% on December 9, 2024; 11,948 were granted on May 4, 2023, that will vest in 1/3 increments on May 4, 2024, May 4, 2025, and May 4, 2026.
All RSU vestings are subject to continued service through each applicable date.

F2: On May 4, 2023, the reporting person was granted 80,049 stock appreciation rights that will vest in 1/3 increments on May 4, 2024, May 4, 2025, and May 4,
2026.